VA-INTELSAT
23.3.2022 14:02:14 CET | Business Wire | Press release
Intelsat , operator of the world’s largest integrated satellite and terrestrial network and leading provider of inflight connectivity (IFC), is donating a pioneering piece of satellite history to the Smithsonian’s National Air and Space Museum in Washington, DC. The company will transfer the ground spare of the Intelsat 1 satellite in a ceremony today at the museum’s Steven F Udvar-Hazy Center near Washington Dulles International Airport.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220323005147/en/
Intelsat 1, also known as Early Bird, was the first commercial communications satellite in geosynchronous orbit launched April 6, 1965. During the early age of space technology, two identical satellites were often constructed in the event of launch failure. Today’s donation is a fully constructed satellite that had been on display at Intelsat’s U.S. headquarters.
Through its four years of service, Intelsat 1 played a historic role in connecting humanity. It is credited with broadcasting the Apollo 11 moon landing to millions of TV viewers around the world, doubling the number of telephone lines between the continents, and providing other critical telecommunications and broadcasting services. Intelsat 1 was also the first satellite to provide direct and nearly instantaneous contact between Europe and North America.
“This historic satellite’s new home commemorates its role in some of the most profound moments in human space exploration and global connectivity. Allowing people to witness the moon landing live inspired a generation of space explorers and enthusiasts. This reminder of Intelsat’s integral part in driving humanity forward only underscores how far Intelsat has come today and will continue to go in connecting our world,” said Intelsat CEO Stephen Spengler.
“We are excited to collect the ground spare of the first commercial communications satellite to be placed in geosynchronous orbit,” said Jim David, curator at the National Air and Space Museum. “The Intelsat 1 satellite will be a featured among iconic artifacts like the Hubble space telescope and Skylab in a new exhibition opening in 2025.”
The satellite will be restored and prepared for exhibition at the museum’s Steven F. Udvar-Hazy Center in Chantilly, Virginia. The satellite will eventually be displayed among other spacecraft in a new exhibition, scheduled to open in 2025, as part of the museum’s renovation of its building in Washington, DC.
Intelsat 1 emphasizes Intelsat’s role as the foundational architect of satellite technology – past, present and future. Intelsat's mission is to make broadband more accessible worldwide. With a 50-year record of delivering seamless and secure coverage to government and industry leaders across 200+ countries, the company is investing $2B, initially, to build a unified, global network that will support virtually any access technology, enabling the next generation of global mobility, IoT and 5G services.
To learn more about Early Bird’s history, click here .
For media b-roll, click here .
About Intelsat
As the foundational architects of satellite technology, Intelsat operates the world’s most trusted satellite telecom network. We apply our unparalleled expertise and global scale to connect people, businesses, and communities, no matter how difficult the challenge. Intelsat is building the future of global communications with the world’s first hybrid, multi-orbit, software-defined 5G network designed for simple, seamless, and secure coverage precisely when and where our customers most need it. Follow the leader in global connectivity and “Imagine Here,” with us, at Intelsat.com .
Follow Us on Social Media
:
Twitter
| LinkedIn
| Facebook
| Instagram
| YouTube
View source version on businesswire.com: https://www.businesswire.com/news/home/20220323005147/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
